廣發證券(01776.HK):廣發控股(香港)擬為廣發全球資本發行不超10億美元結構化票據提供擔保
格隆匯 2 月 5日丨廣發證券(01776.HK)公佈,為滿足業務發展需要,公司全資子公司廣發控股(香港)有限公司(以下簡稱"廣發控股(香港)")擬為其全資子公司廣發全球資本有限公司(以下簡稱"廣發全球資本")發行總規模不超過10億美元(或等值的其他貨幣)的結構化票據提供履約擔保,以保證廣發全球資本將按照票據條款執行票據合約,擔保金額為不超過10億美元(或等值的其他貨幣)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.